The Cross-Border Biotech Blog
"The business, law and policy of the bio economy."
Author: Jeremy Grushcow is a foreign legal consultant at Ogilvy Renault in Toronto. Dani Peters is a lobbyist at Fabiani & Co. in Washington, D.C.
Blawg Related Categories: Corporate Law • Health Law • Intellectual Property Law • Legislation & Lobbying • Science & Technology Law • Securities Law • International • North America • Canada
Recent Posts from The Cross-Border Biotech Blog
-
Bill for U.S. Domestic Production of Medical Isotopes Passed by House of Representatives
The shut-down of Ontario’s Chalk River reactor, which used to supply 30% of the world’s medical isotope requirements, and 60% of U.S. isotope needs, has prompted Congressional action in the U.S. Yesterday, the House passed H.R.…
-
Friday Science Review: November 6, 2009
Just two stories this week – a cancer pathway and innovative dipsticks… New Relationship between Tumour Suppressor Genes: Knocking out genes in mice believed to play a tumour inhibiting role would intuitively result in rapid…
-
Canadian Announcement on Merck–Schering-Plough Transaction Closing
Merck closed its merger with Schering-Plough yesterday, following regulatory clearance in China and Mexico. They held press events yesterday and today, and this morning they appear to have released country-specific announcments. Here’s the blurb on…
-
Trends Update — IP Constituencies: China On the Rise as an IP Enforcer
We have been tracking increased innovative activity in India and China as part of this blog’s Trends in 2009 series, because it has the potential to impact the constituencies that negotiate the IP aspects of…
-
Monday Biotech Deal Review: November 2, 2009
In this week’s Deal Review: SemBioSys hops on the SIFT Tax bandwagon; new deals from Microbix, OPMEDIC and GeneNews; and good updates from iCo Therapeutics, QLT, Noveko and Oncolytics. SemBioSys Joins the SIFT Tax Conversion…
-
This Week in the Twitterverse
A lot of my tweeting this week was live reporting/commentary/snark from the first ever Canadian Science Policy Conference. The conference was a great success and will hopefully spur continued reflection and action in the coming…
-
Ontario H1N1 Swine Flu Update October 31: All Indicators Still Increasing. 2 New Deaths, 10 Toronto Clinics
Checking out this week’s Influenza Bulletin, indications are that the Fall’s Swine Flu outbreak in Ontario is going to get worse before it gets better. Unfortunately, the vaccine is just starting to become available. This coming…
-
Friday Science Review: October 30, 2009
Regenerative medicine and Cross-border awards… Gene Therapy Saves Donor Lungs: A technique using gene therapy on donor lungs before transplantation may be used to repair and save damaged lungs, making them potentially suitable for transplantation…
-
Gairdner Breakfast: Nobel and Gairdner Winners Discuss Biotech and Pharma’s Pipeline Problems
As part of the Gairdner Foundation’s 50th anniversary celebrations this week, there was a breakfast panel this morning with a lot of brainpower (even for MaRS). Cal Stiller lead a discussion by David Baltimore, Phillip Sharp…
-
Bruce Alberts’ Two Strategies to Promote the Impact of Science on Policy
In Bruce Alberts‘ keynote tonight kicking off Canada’s first Science Policy Conference, he highlighted two approaches to increasing the role of science on policy decisions. Here they are: To spread science, we need to spread…